Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.81	2.43	5.9	12.11	29.21	11.12
Cash & Short-Term Investments	4.81	2.43	5.9	12.11	29.21	11.12
Cash Growth	46.46%	-58.74%	-51.27%	-58.56%	162.75%	197.38%
Other Receivables	-	-	-	1.61	-	3.86
Total Trade Receivables	-	-	-	1.61	-	3.86
Other Current Assets	1.26	0.55	0.62	0.8	0.95	0.82
Total Current Assets	6.06	2.99	6.52	14.52	30.16	15.8
Net Property, Plant & Equipment	-	-	-	-	-	0.02
Goodwill	-	-	-	-	8.87	8.87
Other Long-Term Assets	0.03	0.04	0.07	0.13	1.8	0.25
Total Assets	6.1	3.02	6.59	14.65	40.83	24.93
Accounts Payable	1.1	0.94	0.6	2.86	1.54	1.85
Accrued Expenses	0.74	0.35	0.41	1.41	0.57	0.38
Short-Term Debt	-	0.22	0.29	-	-	0.48
Other Current Liabilities	-	-	-	-	-	0.06
Total Current Liabilities	1.85	1.51	1.3	4.27	2.11	2.77
Total Liabilities	1.85	1.51	1.3	4.27	2.11	2.77
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	89.71	83.44	81.64	74.19	70.92	41.59
Retained Earnings	-85.46	-81.92	-76.35	-63.81	-32.2	-19.43
Shareholders' Equity	4.25	1.51	5.29	10.38	38.72	22.16
Total Liabilities & Equity	6.1	3.02	6.59	14.65	40.83	24.93
Total Debt	-	0.22	0.29	0	0	0.48
Net Cash (Debt)	4.81	2.21	5.61	12.11	29.21	10.64
Net Cash Growth	117.37%	-60.56%	-53.66%	-58.56%	174.53%	228.79%
Net Cash Per Share	116.79	413.93	2474.66	8205.77	203397.76	4918244.58
Book Value	4.25	1.51	5.29	10.38	38.72	22.16
Book Value Per Share	103.15	282.79	2332.20	7038.72	269599.02	10241359.36
Tangible Book Value	4.25	1.51	5.29	10.38	29.86	13.29
Tangible Book Value Per Share	103.15	282.79	2332.20	7038.72	207872.37	6143783.22

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.